Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Averion International, a clinical research organization specializing in oncology, cardiovascular diseases and medical devices, has further strengthened its European operations by opening a new office in the Czech Republic.
Subscribe to our email newsletter
The Czech Republic office, located in Prague, is led by Libor Hubacek, country manager for Averion in the Czech Republic. Dr Hubacek will oversee monitoring and regulatory activities for Averion’s studies conducted in the Czech Republic.
This new office is staffed with experienced clinical research associates and clinical trial assistants with additional staff hiring anticipated in the coming months.
Markus Weissbach, CEO of Averion, said: “Averion continues to expand its European footprint to meet the needs of our clients, with the opening of the Averion Czech Republic office.
“In the heart of central eastern Europe, the Czech Republic offers a strong clinical trial environment with large patient populations and well qualified investigators in a broad range of indications. These critical factors are top priorities for our clients and they are vital to the successful conduct of international trials.”